<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02131610</url>
  </required_header>
  <id_info>
    <org_study_id>NCT01475421</org_study_id>
    <secondary_id>PI12/02175</secondary_id>
    <nct_id>NCT02131610</nct_id>
  </id_info>
  <brief_title>Epigenetics Modifications in Obstructive Sleep Apnea</brief_title>
  <acronym>EPIOSA</acronym>
  <official_title>Epigenetics Modifications and Subclinical Atherosclerosis in Obstructive Sleep Apnea: The EPIOSA Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aragon Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Aragones de Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aragon Institute of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Changes in epigenetic regulation of genes involved in systemic inflammation and metabolic
      dysfunction in OSA are linked with accelerated cardiovascular morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design. EPIOSA is a 5-yr non-interventional longitudinal prospective study being conducted at
      the Sleep Clinic of the Hospital Miguel Servet, a large teaching hospital in Zaragoza
      (Spain). Following a baseline visit, subjects are to be followed-up at 3 months, and then
      every year.

      Subject participation. The investigators will enroll a total 300 consecutive OSA male
      patients aged 20-60 yrs, with baseline apnea-hypopnea index â‰¥ 5 events per hour of sleep
      (AHI). In addition, 50 control subjects (AHI &lt; 5) aged 20-60 yrs and matched by body mass
      index (BMI) are also to be recruited. Exclusion criteria will include any comorbid condition
      including alcohol and tobacco use.

      Measurements: Routine clinical assessment, full sleep study, bilateral carotid
      ultrasonography, biochemistry, circulating inflammatory cytokines, T cell subsets and
      epigenetics studies at baseline and every year until at least 5 years of follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of cardiovascular events according with or without the presence of epigenetics changes in pro-inflammatory genes</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>biomarkers in blood and urine that correlates with OSA severity which may serve also as markers of disease progression.</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Snoring</condition>
  <arm_group>
    <arm_group_label>Obstructive slep apnea patients</arm_group_label>
    <description>Patients with OSA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Subjects without OSA</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and plasma samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects that will be study because suspected OSA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 to 60

        Exclusion Criteria:

          -  Any comorbid condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose M Marin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Miguel Servet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose M Marin, M.D.</last_name>
    <phone>+34976765500</phone>
    <email>jmmarint@unizar.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose M Marin, M.D.</last_name>
      <phone>+34 976765500</phone>
      <phone_ext>1941</phone_ext>
      <email>jmmarint@unizar.es</email>
    </contact>
    <investigator>
      <last_name>Maria T Martin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose M Marin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>May 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2014</study_first_posted>
  <last_update_submitted>May 4, 2014</last_update_submitted>
  <last_update_submitted_qc>May 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep apnea</keyword>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Subclinical atherosclerosis</keyword>
  <keyword>Epigenetics</keyword>
  <keyword>T cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

